Allmax TestoFx
Allmax TestoFx, licence 80109136: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Healthy Body Services Inc.
- NPN or DIN-HM
- 80109136
- Status
- Active licence
- Licence date
- 7 April 2021
- Revision date
- 12 March 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1600 mg Potency : 90.0 % Saponins | 80.0 mg | Not calculated |
| Trigonella foenum-graecum Source : Graine Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 4166.75 mg Potency : 80.0 % Glycosides | 166.67 mg | Not calculated |
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 416.65 mg Potency : 0.0 0.05-0.5% Withaferin A | 83.33 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 66.67 mg | Not calculated |
| 3,3'-diindolylméthane Source : 3,3'-diindolylméthane | 66.67 mg | Not calculated |
| Eurycoma longifolia Source : Racine Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 3333 mg | 33.33 mg | Not calculated |
| Serenoa repens Source : Fruit Extraction ratio : 5-8:1 Dry plant equivalent : 266.64 mg Potency : 45.0 % Fatty acids | 33.33 mg | Not calculated |
| Inositol Source : Inositol | 16.67 mg | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 16.34 mg | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 3.16 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | minimum: 19.0 Année(s) | 3.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps promote testosterone production. Supports testosterone production. Supports total testosterone production. Support free testosterone production. Support bioavailable testosterone production. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress. Helps reduce joint discomfort associated with osteoarthritis of the knee. Source of antioxidants. Provides antioxidants for the maintenance of good health. (Provides) An antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80109136
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.